Literature DB >> 12046860

Antidepressant activity of standardized extract of Bacopa monniera in experimental models of depression in rats.

K Sairam1, M Dorababu, R K Goel, S K Bhattacharya.   

Abstract

Bacopa monniera Wettst. (syn. Herpestis monniera L.; Scrophulariaceae) is a commonly used Ayurvedic drug for mental disorders. The standardized extract was reported earlier to have significant anti-oxidant effect, anxiolytic activity and improve memory retention in Alzheimer's disease. Presently, the standardized methanolic extract of Bacopa monniera (bacoside A - 38.0+/-0.9) was investigated for potential antidepressant activity in rodent models of depression. The effect was compared with the standard antidepressant drug imipramine (15 mg/kg, ip). The extract when given in the dose of 20 and 40 mg/kg, orally once daily for 5 days was found to have significant antidepressant activity in forced swim and learned helplessness models of depression and was comparable to that of imipramine.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12046860     DOI: 10.1078/0944-7113-00116

Source DB:  PubMed          Journal:  Phytomedicine        ISSN: 0944-7113            Impact factor:   5.340


  40 in total

Review 1.  Cognitive effects of two nutraceuticals Ginseng and Bacopa benchmarked against modafinil: a review and comparison of effect sizes.

Authors:  Chris Neale; David Camfield; Jonathon Reay; Con Stough; Andrew Scholey
Journal:  Br J Clin Pharmacol       Date:  2013-03       Impact factor: 4.335

2.  Antidepressant activity of brahmi in albino mice.

Authors:  Sldv Ramana Murty Kadali; Das M C; Srinivasa Rao A S R; Karuna Sri G
Journal:  J Clin Diagn Res       Date:  2014-03-15

Review 3.  Advances in tryptophan hydroxylase-2 gene expression regulation: new insights into serotonin-stress interaction and clinical implications.

Authors:  Guo-Lin Chen; Gregory M Miller
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2012-03       Impact factor: 3.568

4.  Behavioral deficit and decreased GABA receptor functional regulation in the hippocampus of epileptic rats: effect of Bacopa monnieri.

Authors:  Jobin Mathew; Gireesh Gangadharan; Korah P Kuruvilla; C S Paulose
Journal:  Neurochem Res       Date:  2010-09-07       Impact factor: 3.996

5.  Alteration in 5-HT₂C, NMDA receptor and IP3 in cerebral cortex of epileptic rats: restorative role of Bacopa monnieri.

Authors:  Amee Krishnakumar; T R Anju; Pretty Mary Abraham; C S Paulose
Journal:  Neurochem Res       Date:  2014-12-13       Impact factor: 3.996

6.  Bacopa monniera (L.) Wettst ameliorates behavioral alterations and oxidative markers in sodium valproate induced autism in rats.

Authors:  T Sandhya; J Sowjanya; B Veeresh
Journal:  Neurochem Res       Date:  2012-02-10       Impact factor: 3.996

7.  Brahmi for the better? New findings challenging cognition and anti-anxiety effects of Brahmi (Bacopa monniera) in healthy adults.

Authors:  Vidya Sathyanarayanan; Tinku Thomas; Suzanne J L Einöther; Rajendra Dobriyal; M K Joshi; Srinivasan Krishnamachari
Journal:  Psychopharmacology (Berl)       Date:  2013-01-26       Impact factor: 4.530

Review 8.  Neuropharmacological review of the nootropic herb Bacopa monnieri.

Authors:  Sebastian Aguiar; Thomas Borowski
Journal:  Rejuvenation Res       Date:  2013-08       Impact factor: 4.663

9.  Neuroprotective role of Bacopa monnieri extract in epilepsy and effect of glucose supplementation during hypoxia: glutamate receptor gene expression.

Authors:  C S Paulose; Finla Chathu; S Reas Khan; Amee Krishnakumar
Journal:  Neurochem Res       Date:  2007-10-18       Impact factor: 3.996

10.  Bacopa monnieri protects SH-SY5Y cells against tert-Butyl hydroperoxide-induced cell death via the ERK and PI3K pathways.

Authors:  Kanoktip Petcharat; Meharvan Singh; Kornkanok Ingkaninan; Jongrak Attarat; Sukkid Yasothornsrikul
Journal:  Siriraj Med J       Date:  2015
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.